Applying Best Clinical Practices to Patients at High Risk of Respiratory Complications

Conditions:   Respiratory Complication;   Obstructive Sleep Apnea Intervention:   Drug: Sugammadex 100 MG/ML [Bridion] Sponsors:   University of California, Los Angeles;   Merck Sharp & Dohme Corp. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials